elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Lenvatinib
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Lenvatinib
RIS
0.001
(Research Intensity Score)
Papers
165
Top papers
Thyroid Cancer
2024 · 638 citations
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
2022 · 947 citations
Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies
2025 · 108 citations
Targeted therapy for hepatocellular carcinoma
2020 · 785 citations
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
2017 · 5946 citations
Newest papers
The RBMS1–SLC7A11 axis regulates ferroptosis susceptibility and lenvatinib sensitivity in hepatocellular carcinoma
2026
TACE-HAIC plus TKIs with/without PD-1 inhibitors for unresectable hepatocellular carcinoma: a propensity score matching study
2026
Editorial: Checkpoint immunotherapy: reshaping the landscape of gastrointestinal cancer treatment, volume II
2026
Targeted Therapies in Endocrine Malignancies
2026
p53-R280S mutation confers lenvatinib resistance in hepatocellular carcinoma via Bcl-2-mediated anti-apoptotic signaling
2026
A sample from the 100 top papers behind Lenvatinib.
Create a free account to browse them all →
Lenvatinib's history
Research intensity over time
Explore Lenvatinib's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Lenvatinib's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link